| Product Code: ETC7379060 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market - Industry Life Cycle |
3.4 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market - Porter's Five Forces |
3.5 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of prostate cancer in Grenada |
4.2.2 Advancements in nuclear medicine technology for prostate cancer diagnostics |
4.2.3 Growing awareness and screening programs for early detection of prostate cancer |
4.3 Market Restraints |
4.3.1 High costs associated with nuclear medicine diagnostics |
4.3.2 Limited access to specialized healthcare facilities offering nuclear medicine services in Grenada |
5 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Trends |
6 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market, By Types |
6.1 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT), 2021- 2031F |
6.1.4 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume, By Photon Emission Computed Tomography (PET), 2021- 2031F |
6.2 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume, By F-18, 2021- 2031F |
6.2.3 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume, By C11, 2021- 2031F |
6.2.4 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume, By GA 68 PSMA, 2021- 2031F |
6.3 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Import-Export Trade Statistics |
7.1 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Export to Major Countries |
7.2 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Imports from Major Countries |
8 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Key Performance Indicators |
8.1 Average waiting time for patients to receive nuclear medicine diagnostics services |
8.2 Number of healthcare facilities in Grenada offering prostate cancer nuclear medicine diagnostics |
8.3 Percentage of men in Grenada undergoing regular prostate cancer screenings |
9 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market - Opportunity Assessment |
9.1 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market - Competitive Landscape |
10.1 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Grenada Prostate Cancer Nuclear Medicine Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here